Evidence map›Paper›PMID 38548771›Full record

ArticleCell discovery2024

Microplastics dampen the self-renewal of hematopoietic stem cells by disrupting the gut microbiota-hypoxanthine-Wnt axis.

Lingli Jiang, Yishan Ye, Yingli Han, Qiwei Wang, Huan Lu, Jinxin Li, Wenchang Qian, Xin Zeng, Zhaoru Zhang, Yanmin Zhao and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell discovery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
25.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 58 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Real-ambient PMParticle and fibre toxicology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 3 institutions in 1 country.

Lingli Jiang *Center for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yishan Ye *Liangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China.
Yingli Han *Center for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Qiwei Wang *Center for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.ORCID http://orcid.org/0000-0001-9197-3163
Huan LuCenter for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Jinxin LiCenter for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Wenchang QianCenter for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Xin ZengCenter for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Zhaoru ZhangCenter for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.
Yanmin ZhaoLiangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China.
Jimin ShiLiangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China.
Yi LuoLiangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China.
Yunfei QiuLiangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China.
Jun SunLiangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China.
Jinghao ShengLiangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China.
He HuangLiangzhu Laboratory, Zhejiang University, Hangzhou, Zhejiang, China. huanghe@zju.edu.cn.ORCID http://orcid.org/0000-0002-2723-1621
Pengxu QianCenter for Stem Cell and Regenerative Medicine and Bone Marrow Transplantation Center of the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China. axu@zju.edu.cn.ORCID http://orcid.org/0000-0001-5636-6704
First Affiliated Hospital Zhejiang University · CNZhejiang Lab · CNZhejiang University · CN

Funding

China Postdoctoral Science Foundation 2021M702853National Natural Science Foundation of China (National Science Foundation of China) 82000149National Natural Science Foundation of China (National Science Foundation of China) 82222003National Natural Science Foundation of China (National Science Foundation of China) 82370105National Natural Science Foundation of China (National Science Foundation of China) 92268117Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) LQ21H180006Natural Science Foundation of Zhejiang Province (Zhejiang Provincial Natural Science Foundation) Z24H080001
6 · The paper itself

Abstract

Microplastics (MPs) are contaminants ubiquitously found in the global biosphere that enter the body through inhalation or ingestion, posing significant risks to human health. Recent studies emerge that MPs are present in the bone marrow and damage the hematopoietic system. However, it remains largely elusive about the specific mechanisms by which MPs affect hematopoietic stem cells (HSCs) and their clinical relevance in HSC transplantation (HSCT). Here, we established a long-term MPs intake mouse model and found that MPs caused severe damage to the hematopoietic system. Oral gavage administration of MPs or fecal transplantation of microbiota from MPs-treated mice markedly undermined the self-renewal and reconstitution capacities of HSCs. Mechanistically, MPs did not directly kill HSCs but disrupted gut structure and permeability, which eventually ameliorated the abundance of Rikenellaceae and hypoxanthine in the intestine and inactivated the HPRT-Wnt signaling in bone marrow HSCs. Furthermore, administration of Rikenellaceae or hypoxanthine in mice as well as treatment of WNT10A in the culture system substantially rescued the MPs-induced HSC defects. Finally, we validated in a cohort of human patients receiving allogenic HSCT from healthy donors, and revealed that the survival time of patients was negatively correlated with levels of MPs, while positively with the abundance of Rikenellaceae, and hypoxanthine in the HSC donors' feces and blood. Overall, our study unleashes the detrimental roles and mechanisms of MPs in HSCs, which provides potential strategies to prevent hematopoietic damage from MPs and serves as a fundamental critique for selecting suitable donors for HSCT in clinical practice.

Identifiers

PMID38548771
PMCPMC10978833
OpenAlexW4393315651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.